JPY 1952.0
(1.56%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 36.09 Billion | 35.95 Billion | 24.21 Billion | 19.11 Billion | 19.06 Billion | 17.22 Billion |
Cost of Revenue | 29.75 Billion | 30.25 Billion | 19.88 Billion | 15.49 Billion | 15.16 Billion | 13.43 Billion |
Gross Profit | 6.34 Billion | 5.7 Billion | 4.33 Billion | 3.62 Billion | 3.89 Billion | 3.78 Billion |
Operating Expenses | 3.08 Billion | 3.07 Billion | 2.47 Billion | 2.32 Billion | 2.29 Billion | 2.32 Billion |
Selling, General and Administrative Expenses | 3.08 Billion | 3.06 Billion | 2.46 Billion | 2.31 Billion | 2.29 Billion | 0.07 |
Research and Development Expenses | - | 0.07 | 0.08 | 0.06 | 0.10 | 0.08 |
Other Expenses | - | 3.07 Billion | 2.47 Billion | 2.32 Billion | 2.29 Billion | -45.2 Million |
Cost and Expenses | 32.83 Billion | 33.32 Billion | 22.35 Billion | 17.81 Billion | 17.45 Billion | 15.76 Billion |
Operating Income | 3.26 Billion | 2.62 Billion | 1.85 Billion | 1.3 Billion | 1.6 Billion | 1.46 Billion |
Interest Expense | 77 Million | 80 Million | 73.97 Million | 64.11 Million | 48.98 Million | 62.38 Million |
Income Tax Expense | 1.05 Billion | 782 Million | 534.19 Million | 304 Million | 201.03 Million | 162.64 Million |
Earnings before Tax | 3.13 Billion | 2.47 Billion | 2.01 Billion | 1.09 Billion | 1.87 Billion | 1.32 Billion |
Net Income | 2.06 Billion | 1.69 Billion | 1.48 Billion | 800.9 Million | 1.67 Billion | 1.16 Billion |
Earnings Per Share Basic | 84.78 | 69.80 | 61.22 | 33.01 | 70.00 | 50.94 |
Earnings Per Share Diluted | 84.71 | 69.73 | 60.91 | 32.83 | 69.33 | 50.12 |
Weighted Average Shares Outstanding | 24.32 Million | 24.26 Million | 24.19 Million | 24.26 Million | 23.94 Million | 22.82 Million |
Weighted Average Shares Outstanding (Diluted) | 24.34 Million | 24.29 Million | 24.31 Million | 24.39 Million | 24.17 Million | 23.19 Million |
Gross Margin | 0.18 | 0.16 | 0.18 | 0.19 | 0.20 | 0.22 |
EBIT Margin | 0.10 | 0.08 | 0.09 | 0.08 | 0.09 | 0.09 |
Profit Margin | 0.06 | 0.05 | 0.06 | 0.04 | 0.09 | 0.07 |
EBITDA | 3.55 Billion | 2.93 Billion | 2.16 Billion | 1.5 Billion | 1.69 Billion | 1.54 Billion |
Earnings Before Tax Margin | 0.09 | 0.07 | 0.08 | 0.07 | 0.08 | 0.09 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 11.69 Billion | 9.3 Billion | 10.39 Billion | 36.09 Billion | 11.66 Billion | 6.72 Billion |
Cost of Revenue | 9.97 Billion | 7.68 Billion | 8.14 Billion | 29.75 Billion | 10.13 Billion | 5.34 Billion |
Gross Profit | 1.72 Billion | 1.61 Billion | 2.25 Billion | 6.34 Billion | 1.52 Billion | 1.37 Billion |
Operating Expenses | 816 Million | 785 Million | 814 Million | 3.08 Billion | 810 Million | 740 Million |
Selling, General and Administrative Expenses | 816 Million | - | 808 Million | - | 810 Million | 740 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 5 Million | -785 Million | -814 Million | -3.08 Billion | -2 Million | -738 Million |
Cost and Expenses | 10.78 Billion | 8.46 Billion | 8.95 Billion | 32.83 Billion | 10.94 Billion | 6.08 Billion |
Operating Income | 907 Million | 834 Million | 1.44 Billion | 3.26 Billion | 719 Million | 635 Million |
Interest Expense | 22 Million | 19 Million | 19 Million | 77 Million | 20 Million | 20 Million |
Income Tax Expense | 303 Million | 227 Million | 384 Million | 1.05 Billion | 264 Million | 240 Million |
Earnings before Tax | 910 Million | 834 Million | 1.18 Billion | 3.13 Billion | 701 Million | 780 Million |
Net Income | 604 Million | 608 Million | 795 Million | 2.06 Billion | 435 Million | 541 Million |
Earnings Per Share Basic | 24.78 | 24.99 | 32.67 | - | 17.88 | 22.26 |
Earnings Per Share Diluted | 24.74 | 24.98 | 32.67 | - | 17.86 | 22.24 |
Weighted Average Shares Outstanding | 24.37 Million | 24.33 Million | 24.33 Million | 24.32 Million | 24.33 Million | 24.3 Million |
Weighted Average Shares Outstanding (Diluted) | 24.41 Million | 24.33 Million | 24.33 Million | 24.34 Million | 24.35 Million | 24.32 Million |
Gross Margin | 0.15 | 0.17 | 0.22 | 0.18 | 0.13 | 0.20 |
EBIT Margin | 0.08 | 0.10 | 0.15 | - | 0.06 | 0.12 |
Profit Margin | 0.05 | 0.07 | 0.08 | 0.06 | 0.04 | 0.08 |
EBITDA | 969 Million | 903 Million | 1.51 Billion | - | 721 Million | 800 Million |
Earnings Before Tax Margin | 0.08 | 0.09 | 0.14 | 0.09 | 0.06 | 0.09 |
GZTGF
9530
1618
4015
NGLFINE
THEMISMED